Sign in

CIK 0001826667 · Non-accelerated filer<br>Smaller reporting company

TriSalus Life Sciences, Inc.

Sign in to watch
Ticker
TLSI
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
853009869
Phone
415 336 8917
Business address
6272 WEST 91ST AVENUE, WESTMINSTER, CO, 80031
Former names
MedTech Acquisition Corp, MedTech Acquisition Corporation

Securities

  • TLSI Common Stock Nasdaq
  • TLSIW Warrant Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,113
in 3 filings

Net −$4,113. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Marshak Richard −$1K Chief Commercial Officer sold <1% of stake
  2. Stevens Jennifer −$1K Chief Regulatory Officer sold <1% of stake
  3. Cox Bryan F. −$1K Chief of Research sold <1% of stake

Reading 26 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-05-14 Wahlstrom Mats Director Grant or award · Director Stock Option (right to buy) +75,204 276,149
2026-05-14 Gordon Gary B. Director Grant or award +28,201 37,957
2026-05-14 Gordon Gary B. Director Grant or award +24,553 62,510
2026-05-14 Gordon Gary B. Director Grant or award · Director Stock Option (right to buy) +56,403 112,653
2026-05-14 MATLIN DAVID J Director Grant or award +28,201 1,300,145
2026-05-14 MATLIN DAVID J Director Grant or award +23,065 1,323,210
2026-05-14 MATLIN DAVID J Director Grant or award · Director Stock Option (right to buy) +56,403 121,403
2026-05-14 Valle William Director Grant or award +28,201 58,688
2026-05-14 Valle William Director Grant or award +24,553 83,241
2026-05-14 Valle William Director Grant or award · Director Stock Option (right to buy) +56,403 112,653
2026-05-14 Stansky Michael P Director Grant or award +23,501 810,633
2026-05-14 Stansky Michael P Director Grant or award +20,089 830,722
2026-05-14 Stansky Michael P Director Grant or award · Director Stock Option (right to buy) +47,003 139,540
2026-03-17 Szela Mary T CEO and President Sale −15,944 $3.85 $61K 752,987
2026-03-16 Devlin Jodi Chief of Clinical Operations Sale −273 $4.12 $1K 97,364
2026-03-16 Cox Bryan F. Chief of Research Sale −579 $4.12 $2K 163,415
2026-03-16 Marshak Richard Chief Commercial Officer Sale −419 $4.12 $2K 110,397
2026-03-16 Stevens Jennifer Chief Regulatory Officer Sale −774 $4.12 $3K 124,110
2026-03-12 Devlin Jodi Chief of Clinical Operations Sale −1,772 $4.09 $7K 97,637
2026-03-12 Cox Bryan F. Chief of Research Sale −1,467 $4.09 $6K 163,994

Page 2 of 9 · 161 trades